Barron's Streetwise
Barron's Streetwise
Barron's
The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce
32 minutes Posted Dec 8, 2023 at 9:05 pm.
0:00
32:32
Download MP3
Show notes

A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.

Learn more about your ad choices. Visit megaphone.fm/adchoices